Get Free Delivery With No Minimum Order



THIOTACID 600/MG FC TAB 30/TAB
- Sku : I-031929
Key features
THIOTACID 600 mg film-coated tablets contain 600 mg of Alpha Lipoic Acid (ALA) per tablet. The formulation provides potent antioxidant support, supports nerve function commonly affected in diabetic peripheral neuropathy, and supports insulin sensitivity and healthy glucose metabolism. THIOTACID delivers racemic R/S‑ALA - with the R‑enantiomer being the biologically active form - and exhibits oral bioavailability of approximately 30-40% due to first‑pass metabolism; the film-coated tablet enhances stability. Serving size is one film-coated tablet, and each pack contains 30 tablets.- Brand: THIOTACID
- Supplement Type: Antioxidant
- Active Compounds: Alpha Lipoic Acid (ALA) 600mg per film-coated tablet
- Supplement Form: Film-Coated Tablet
- Serving Size: 1 film-coated tablet
- Servings Per Container: 30
- Pack Size: 30 Tablets
- Primary Benefit: Provides potent antioxidant protection, supports nerve function in diabetic peripheral neuropathy, and improves insulin sensitivity and glucose metabolism.
- Bioavailability Form: Alpha Lipoic Acid (racemic R/S-ALA) - the R-form is the biologically active enantiomer; oral bioavailability is approximately 30-40% due to first-pass metabolism
- Prescription Status: OTC
- Certification: SFDA registered (Registration No. 609234147); manufactured under GMP by Eva Pharma, Egypt
- Manufacturer: EVA PHARMA
- Country of Origin: Egypt
- SFDA Registration No.: 609234147
- Shelf Life: 36 months
- Plant Source: Not applicable - Alpha Lipoic Acid is a naturally occurring organosulfur compound synthesized endogenously in humans and animals; not derived from a plant source
- Standardized Extract: Not applicable - Alpha Lipoic Acid is a defined synthetic/semi-synthetic compound (600mg per tablet), not a standardized botanical extract
Benefits & Uses
Primary Benefit
Provides potent antioxidant protection, supports nerve function in diabetic peripheral neuropathy, and improves insulin sensitivity and glucose metabolism.
Health Claims
Clinically supported for reduction of symptoms of diabetic peripheral neuropathy; potent antioxidant activity reducing oxidative stress; improvement of insulin sensitivity and glucose uptake; supports mitochondrial energy metabolism.
Common Deficiency Symptoms
Alpha lipoic acid is synthesized endogenously; deficiency is not a recognized clinical condition, but low levels are associated with increased oxidative stress, peripheral neuropathy symptoms, and impaired glucose metabolism.
Target Population
Adults with diabetic peripheral neuropathy, individuals with type 2 diabetes, patients with metabolic syndrome, adults seeking antioxidant support, individuals with oxidative stress-related conditions.
Scientific Evidence Level
Strong
Usage & Dosage
Suggested Use
Take 1 tablet daily, preferably 30 minutes before a meal on an empty stomach.
Serving Size
1 film-coated tablet
Servings Per Container
30
Best Time to Take
30 minutes before a meal on an empty stomach for optimal absorption; morning for metabolic goals or evening for neuropathy symptom management.
Recommended Daily Intake
Adults: 600mg/day for therapeutic use (diabetic neuropathy); general antioxidant use: 100-300mg/day.
Upper Tolerable Limit
No established official upper tolerable limit; clinical studies have used up to 1800mg/day without serious adverse effects; doses above 600mg/day should be medically supervised.
Absorption Enhancers
Taking on an empty stomach increases peak plasma concentration; R-ALA form has superior bioavailability compared to S-ALA.
Absorption Inhibitors
Food can significantly reduce the absorption and bioavailability of Alpha Lipoic Acid.
Side Effects
Possible Side Effects
Generally well-tolerated at 600mg/day; possible side effects include nausea, vomiting, stomach upset, skin rash (rare), headache, and hypoglycemia in diabetic patients on concurrent antidiabetic therapy.
Toxicity Risk
Low
Upper Tolerable Limit
No established official upper tolerable limit; clinical studies have used up to 1800mg/day without serious adverse effects; doses above 600mg/day should be medically supervised.
Special Populations
Target Population
Adults with diabetic peripheral neuropathy, individuals with type 2 diabetes, patients with metabolic syndrome, adults seeking antioxidant support, individuals with oxidative stress-related conditions.
Storage & Patient Advice
SFDA Storage Conditions
do not store above 25°c
Patient Counseling
Take 1 tablet (600 mg) orally once daily, preferably on an empty stomach about 30 minutes before food to optimize absorption; if gastrointestinal upset occurs, it may be taken with food. If you have diabetes or use insulin/oral glucose‑lowering medicines, monitor blood glucose more closely as alpha‑lipoic acid may lower glucose. If you have thyroid disease or take thyroid hormone (e.g., levothyroxine), consult your clinician and separate administration by at least 2 hours. Avoid heavy alcohol use (risk of thiamine deficiency/neuropathy). Do not exceed the recommended dose without medical advice. Store below 25°C.
Science & Evidence
Bioavailability Form
Alpha Lipoic Acid (racemic R/S-ALA) - the R-form is the biologically active enantiomer; oral bioavailability is approximately 30-40% due to first-pass metabolism
Water or Fat Soluble
Both water- and fat-soluble
Scientific Evidence Level
Strong
Product Information
Supplement Type
Antioxidant
Certification
SFDA registered (Registration No. 609234147); manufactured under GMP by Eva Pharma, Egypt
Plant Source
Not applicable - Alpha Lipoic Acid is a naturally occurring organosulfur compound synthesized endogenously in humans and animals; not derived from a plant source
Standardized Extract
Not applicable - Alpha Lipoic Acid is a defined synthetic/semi-synthetic compound (600mg per tablet), not a standardized botanical extract
-1744229570.gif)



